Danaher Co. (NYSE:DHR) Shares Sold by Horizon Kinetics Asset Management LLC

Horizon Kinetics Asset Management LLC lowered its position in Danaher Co. (NYSE:DHRFree Report) by 1.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,871 shares of the conglomerate’s stock after selling 137 shares during the quarter. Horizon Kinetics Asset Management LLC’s holdings in Danaher were worth $2,466,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in DHR. Canton Hathaway LLC increased its position in Danaher by 1.5% during the third quarter. Canton Hathaway LLC now owns 11,725 shares of the conglomerate’s stock worth $3,260,000 after buying an additional 175 shares in the last quarter. Truvestments Capital LLC acquired a new stake in shares of Danaher during the third quarter valued at $110,000. Loomis Sayles & Co. L P increased its position in Danaher by 1.8% during the 3rd quarter. Loomis Sayles & Co. L P now owns 961,226 shares of the conglomerate’s stock worth $267,240,000 after purchasing an additional 16,740 shares in the last quarter. Blue Whale Capital LLP raised its stake in Danaher by 39.9% in the 3rd quarter. Blue Whale Capital LLP now owns 259,466 shares of the conglomerate’s stock valued at $72,137,000 after purchasing an additional 73,966 shares during the last quarter. Finally, DRW Securities LLC lifted its holdings in Danaher by 100.1% in the 3rd quarter. DRW Securities LLC now owns 3,081 shares of the conglomerate’s stock valued at $857,000 after purchasing an additional 1,541 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Evercore ISI upped their price objective on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. KeyCorp increased their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 23rd. Wells Fargo & Company started coverage on Danaher in a research note on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 price target on the stock. Raymond James dropped their price objective on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Finally, Royal Bank of Canada decreased their target price on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $287.16.

Read Our Latest Analysis on DHR

Danaher Stock Up 0.8 %

Shares of Danaher stock opened at $237.77 on Monday. Danaher Co. has a 1-year low of $215.68 and a 1-year high of $281.70. The company has a market capitalization of $171.74 billion, a PE ratio of 45.01, a P/E/G ratio of 4.34 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The business has a 50-day moving average of $258.15 and a 200-day moving average of $260.03.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business’s revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.02 earnings per share. As a group, equities analysts forecast that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio is presently 20.61%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.